Ostrum Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $174K | Sell |
|
|||||
|
2025
Q2 | $128K | Sell |
|
|||||
|
2025
Q1 | $110K | Sell |
|
|||||
|
2024
Q4 | $98.1K | Sell |
|
|||||
|
2024
Q3 | $1.21M | Sell |
|
|||||
|
2024
Q2 | $1.4M | Sell |
|
|||||
|
2024
Q1 | $925K | Hold |
|
|||||
|
2023
Q4 | $1.18M | Buy |
|
|||||
|
2023
Q3 | $80.6K | Sell |
|
|||||
|
2023
Q2 | $87.2K | Buy |
|
|||||
|
2023
Q1 | $91.7K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $308K | Buy |
|